Live tape
Top 8, mentions 7d15,265NVDA6,540 mentions▲ +0.04GOOGL1,864 mentions▲ +0.04SPY1,671 mentions▲ +0.05QQQ1,446 mentions▲ +0.05SPCX1,139 mentions▲ +0.06AMD950 mentions▲ +0.08MSFT842 mentions▲ +0.03CRWV813 mentions▲ +0.07

Equity · Healthcare

IRMD

NASDAQ

Iradimed (IRMD)

97.03 USD −0.65% vs prior close
IRADIMED CORPORATION price graph

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.

Track this symbol on TradingView
Market cap
1.2B USD
P/E (TTM)
51.9
Revenue, year to Dec 2025
83.8M USD
EPS, diluted, year to Dec 2025
1.75 USD
52-week range
56.21 USD – 105 USD
Avg volume
23.5K

as of Jul 17, 2026

Have Iradimed (IRMD) insiders bought or sold shares recently?

In the 90 days to 11 Nov 2026, Iradimed insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 20 Nov 2025, show no open-market purchase.

Form 4, 90 days to 11 Nov 2026, newest reported trade 3 Sep 2026

0buys
1sells
$123Knet sold
1other filings
Have Iradimed (IRMD) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
03 Sep 2026ALLEN MONTY KDirectorSell1,419123K USD
1 other filing in the window: a grant, exercise, tax withholding or transfer, not a trade
Have Iradimed (IRMD) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
23 Sep 2026KIANI JOE EDirectorOption exercise698

Which funds hold Iradimed (IRMD)?

7 of the 45 institutional funds we track reported a Iradimed position for the quarter ended 30 Jun 2026 — a combined 66.2M USD; the latest of those filings landed 02 Sep 2026.

Form 13F

Which funds hold Iradimed (IRMD)?
FundPositionSharesValueShares q/q
Renaissance TechnologiesHeld (±25%)394,41237.7M USD−10.5%
Two Sigma InvestmentsHeld (±25%)182,89417.5M USD+10.4%
Tudor Investment CorpTrimmed45,6264.4M USD−36.5%
Marshall WaceNew position25,2982.4M USD
AQR Capital ManagementHeld (±25%)17,0021.6M USD+6.8%
Man GroupNew position15,8471.5M USD
Point72 Asset ManagementHeld (±25%)11,9091.1M USD−16.8%
Citadel AdvisorsExited
D. E. Shaw & Co.Exited
Millennium ManagementExited

What has been filed or recorded for Iradimed (IRMD)?

The filings we hold for Iradimed, newest first: 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Sep 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Iradimed (IRMD)?
And
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS 0.51 USDRevenue $24M
30 Sep 2026FinancialsTotal assets121.1M USDat period end
30 Sep 2026FinancialsTotal equity106.5M USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS 0.41 USDRevenue $20M
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS 0.45 USDRevenue $22M
31 Dec 2025Annual reportFY 2025 reportedEPS 1.75 USDRevenue $84M
31 Dec 2025FinancialsRevenue83.8M USDfiscal year
31 Dec 2025FinancialsNet income22.5M USDfiscal year
31 Dec 2025FinancialsDiluted EPS1.75 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS 0.43 USDRevenue $21M
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS 0.45 USDRevenue $20M
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS 0.37 USDRevenue $20M
31 Dec 2024Annual reportFY 2024 reportedEPS 1.50 USDRevenue $73M

What do people ask about Iradimed (IRMD)?

From live data
What is Iradimed’s market cap?1.2B

Iradimed is worth 1.2B USD by market value as of 17 Jul 2026, which is the share price times the shares on issue from its SEC filings.

What is Iradimed’s P/E ratio?51.9

Iradimed has a price-to-earnings ratio of 51.9, as of 17 Jul 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.

What is Iradimed’s revenue?83.8M

Iradimed reported revenue of 83.8M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have Iradimed insiders bought or sold shares recently?1 sale

In the 90 days to 11 Nov 2026, Iradimed insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 20 Nov 2025, show no open-market purchase. A further 1 filing was a grant, award, gift or exercise rather than an open-market trade. See Insiders

Which funds own Iradimed?7 of 45

7 of the 45 funds we track reported a Iradimed position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Renaissance Technologies, Two Sigma Investments and Tudor Investment Corp. See Funds

When did Iradimed last report earnings?0.51

Iradimed last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 0.51 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  6. SEC EDGARreported earnings figures and scheduled report dates
  7. SEC EDGARValuation computed from SEC EDGAR filings